_complex-generics-topical-products-part-2-preview-1.jpg "Complex Generics: Topical Products, Part 2 from usp 1724 chapter Video Screenshot Preview 1")
Gallery_complex-generics-topical-products-part-2-preview-3.jpg "Complex Generics: Topical Products, Part 2 from usp 1724 chapter Video Screenshot Preview 3")
Gallery_complex-generics-topical-products-part-2-preview-hqdefault.jpg "Complex Generics: Topical Products, Part 2 from usp 1724 chapter Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 hour 31 minutes 52 seconds
👁 View: 1K times
Play Audio:👁 View: 1K times
Description:
U.S. Food and Drug Administration
U.S. Food and Drug Administration
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_best-practices-for-topical-generic-product-development-and-anda-submission-session-2.webp "U.S. Food and Drug Administration")
⏲ 54 minutes 12 seconds 👁 481
_maintaining-compliance-with-technology-in-the-era-of-usp-825.webp "Cardinal Health")
_panel-on-development-and-validation-considerations-for-drug-release-and-permeation-testing.webp "U.S. Food and Drug Administration")
⏲ 20 minutes 57 seconds 👁 142
_answering-your-questions-navigating-usp797-final-revisions.webp "Contec, Inc.")
_2021-ivrt-ivpt-workshop-day-2-dr-sam-raney-presentation.webp "Center for Research on Complex Generics (CRCG)")
_cardinal-health-usp-800-ask-the-expert-assessment-of-risk.webp "Cardinal Health")
_container-closure-requirements-preparing-for-usp-382-661-1-amp-661-2.webp "Nelson Labs")
_office-of-study-integrity-and-surveillance-osis-workshop-2022-day-1-session-2.webp "U.S. Food and Drug Administration")
⏲ 1 hour 10 minutes 26 seconds 👁 287
_best-practices-for-topical-generic-product-development-and-anda-submission-session-2.jpg)
_maintaining-compliance-with-technology-in-the-era-of-usp-825.jpg)
_panel-on-development-and-validation-considerations-for-drug-release-and-permeation-testing.jpg)
_answering-your-questions-navigating-usp797-final-revisions.jpg)
_2021-ivrt-ivpt-workshop-day-2-dr-sam-raney-presentation.jpg)
_cardinal-health-usp-800-ask-the-expert-assessment-of-risk.jpg)
_container-closure-requirements-preparing-for-usp-382-661-1-amp-661-2.jpg)
_office-of-study-integrity-and-surveillance-osis-workshop-2022-day-1-session-2.jpg)
![[+]](/images/menu.gif){kind=small}